Mark J. Enyedy, Chief Executive Officer at ImmunoGen, Inc. (IMGN), sold 110,444 shares at $4.99 ($551K) on 2020-02-24, disclosed to the SEC on 2020-02-25.
Seasonal sale ($551k) by Chief Executive Officer — this insider has traded IMGN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 55,222 | $276K | 50.0% |
| 2 | $4.99 | 55,222 | $276K | 50.0% |
| Total | $4.99 avg | 110,444 | $551K | 100% |
| Filing → |
| IMGN | SELL | 2019-02-25 | $286K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $1.5M | — | Filing → |
| IMGN | BUY | 2016-11-09 | $46K | — | Filing → |